Figure 4 | Blood Cancer Journal

Figure 4

From: Whole-exome analysis reveals novel somatic genomic alterations associated with outcome in immunochemotherapy-treated diffuse large B-cell lymphoma

Figure 4

Association of CNAs and mutations with DLBCL time to progression. Kaplan–Meier curves for the association of DLBCL time to progression with gains in (a) Chr 3q27.3 (BCL6, n=4), (b) 11q23.3 (CBL, n=3), (c) 19q13.32 (RELB, n=3), loss in (d) 6q21 (SLC22A16, n=11), a mutation in (e) FOXO1 (n=2) or (f) a combined analysis of the three gains.

Back to article page